company

University of North Carolina, Chapel Hill

University of North Carolina
as of 2026-07-01
Monitor thisAsk about this
at a glance
36 trials sponsored · 37 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

37 assets
AripiprazoleBrexpiprazole (Rexulti)HaloperidolLurasidoneOlanzapinePaliperidoneRisperidoneZiprasidoneAdapted ENHANCE InterventionAerobic exerciseCommunity CareExercise Intervention- PACE-LifeExercise interventionGraduated Recovery Intervention Program (GRIP)Horyzons USAI-CATI-CAT TherapyICBT ProgramIntegrated TreatmentIntranasal Oxytocin SprayLorcaserinMetforminMicronized ProgesteroneMolindonePACE-LifePyridoxineRaclopride C11Social Cognition and Interaction Training (SCIT)Steps for Achieving Financial Empowerment (SAFE)Stretching and Toning ExerciseTDCSTelehealthTransdermal Estradiolintranasal spray with oxytocinnasal spray without oxytocintACS (alpha)tACS treatment week

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Aripiprazole
small molecule
drug
Brexpiprazole (Rexulti)
small molecule
drug
Haloperidol
small molecule
drug
Lurasidone
small molecule
drug
Olanzapine
small molecule
drug
Paliperidone
small molecule
drug
Risperidone
small molecule
drug
Ziprasidone
small molecule
drug